Nulytely

Constipation, Exophthalmos, Bowel preparation therapy + 8 more

Treatment

3 FDA approvals

20 Active Studies for Nulytely

What is Nulytely

Polyethylene glycol

The Generic name of this drug

Treatment Summary

Sodium bicarbonate is a white powder that is often used to help regulate the acidity in the body, replace lost electrolytes, and balance the body's pH levels. It is also used in some topical cleansing products.

GoLYTELY

is the brand name

image of different drug pills on a surface

Nulytely Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

GoLYTELY

Polyethylene glycol

1984

207

Approved as Treatment by the FDA

Polyethylene glycol, also known as GoLYTELY, is approved by the FDA for 3 uses such as Constipation and Constipation .

Constipation

Constipation

Constipation

Effectiveness

How Nulytely Affects Patients

Sodium bicarbonate given through an IV can help balance the acid levels in the blood and raise the pH, reversing signs and symptoms of acidosis.

How Nulytely works in the body

Sodium bicarbonate is a medicine that helps to reduce acidity in the body. It helps to raise the pH level of blood, which helps to normalize any acidosis that may have occurred. Sodium bicarbonate also helps to increase the pH level of urine, which may help dissolve certain types of kidney stones. It can also act as an antacid in the stomach, neutralizing excess acid in the stomach and providing relief from acid reflux symptoms.

When to interrupt dosage

The prescribed dosage of Nulytely is contingent upon the diagnosed condition, such as Perfusion Scintigraphy, Myocardial Perfusion Imaging and Chronic Constipation. The quantity of dosage fluctuates, in line with the technique of delivery (e.g. Solution or Powder, for solution) featured in the table below.

Condition

Dosage

Administration

Dry Eye Syndrome

, 1.7 mg/mg, 236.0 mg/mL, 17000.0 mg, 1700.0 mg/hour, 420.0 mg/mL, 17.0 mg/mg, 2.4 mg/mg, 4.2 mg/mg, 2.36 mg/mg, 227.1 mg/mL, 210.0 mg/mL, 1.0 mg/mg, 0.55 mg/mg, 100.0 %, 1.0 %, 15.0 %, 236000.0 mg, 59550.0 mg, 238180.0 mg, 14750.0 mg, 59000.0 mg, 240.0 mg/mL, 10.0 mg/mL, 150.0 mg/mL, 210000.0 mg, 0.15 mg/mg, 100.0 mg/mL, 40000.0 mg, 60.0 mg/mL, 100000.0 mg, 0.2 %, 140000.0 mg, 17000.0 mg/dose, 160.0 mg/mL, 0.152 mg/mg, 0.85769 mg/mg, 59.55 mg/mL, 2.388 mg/mg, 2.382 mg/mg

Oral, , Powder, for solution, Powder, for solution - Oral, Powder, Powder - Oral, Powder, for solution - Topical, Topical, Cream, Cream - Topical, Liquid, Liquid - Ophthalmic, Ophthalmic, Gel - Nasal, Gel, Kit; Powder, for solution; Tablet, delayed release - Oral, Nasal, Spray, Gel - Topical, Solution, Solution - Oral, Liquid - Oral, Powder - Topical, Aerosol, metered - Nasal, Aerosol, metered, Powder, for suspension - Oral, Spray - Nasal, Kit - Oral, Kit, Powder, for solution - Nasogastric; Oral, Nasogastric; Oral, Kit - Oral; Topical, Oral; Topical, Nasogastric, Powder, for solution - Nasogastric, Oral; Rectal, Powder, for suspension, Kit; Powder, for solution; Tablet, delayed release, Spray, metered, Spray, metered - Nasal, Solution - Ophthalmic, Solution / drops, Solution / drops - Ophthalmic

Colon Cleansing for Colonoscopy

, 1.7 mg/mg, 236.0 mg/mL, 17000.0 mg, 1700.0 mg/hour, 420.0 mg/mL, 17.0 mg/mg, 2.4 mg/mg, 4.2 mg/mg, 2.36 mg/mg, 227.1 mg/mL, 210.0 mg/mL, 1.0 mg/mg, 0.55 mg/mg, 100.0 %, 1.0 %, 15.0 %, 236000.0 mg, 59550.0 mg, 238180.0 mg, 14750.0 mg, 59000.0 mg, 240.0 mg/mL, 10.0 mg/mL, 150.0 mg/mL, 210000.0 mg, 0.15 mg/mg, 100.0 mg/mL, 40000.0 mg, 60.0 mg/mL, 100000.0 mg, 0.2 %, 140000.0 mg, 17000.0 mg/dose, 160.0 mg/mL, 0.152 mg/mg, 0.85769 mg/mg, 59.55 mg/mL, 2.388 mg/mg, 2.382 mg/mg

Oral, , Powder, for solution, Powder, for solution - Oral, Powder, Powder - Oral, Powder, for solution - Topical, Topical, Cream, Cream - Topical, Liquid, Liquid - Ophthalmic, Ophthalmic, Gel - Nasal, Gel, Kit; Powder, for solution; Tablet, delayed release - Oral, Nasal, Spray, Gel - Topical, Solution, Solution - Oral, Liquid - Oral, Powder - Topical, Aerosol, metered - Nasal, Aerosol, metered, Powder, for suspension - Oral, Spray - Nasal, Kit - Oral, Kit, Powder, for solution - Nasogastric; Oral, Nasogastric; Oral, Kit - Oral; Topical, Oral; Topical, Nasogastric, Powder, for solution - Nasogastric, Oral; Rectal, Powder, for suspension, Kit; Powder, for solution; Tablet, delayed release, Spray, metered, Spray, metered - Nasal, Solution - Ophthalmic, Solution / drops, Solution / drops - Ophthalmic

Constipation

, 1.7 mg/mg, 236.0 mg/mL, 17000.0 mg, 1700.0 mg/hour, 420.0 mg/mL, 17.0 mg/mg, 2.4 mg/mg, 4.2 mg/mg, 2.36 mg/mg, 227.1 mg/mL, 210.0 mg/mL, 1.0 mg/mg, 0.55 mg/mg, 100.0 %, 1.0 %, 15.0 %, 236000.0 mg, 59550.0 mg, 238180.0 mg, 14750.0 mg, 59000.0 mg, 240.0 mg/mL, 10.0 mg/mL, 150.0 mg/mL, 210000.0 mg, 0.15 mg/mg, 100.0 mg/mL, 40000.0 mg, 60.0 mg/mL, 100000.0 mg, 0.2 %, 140000.0 mg, 17000.0 mg/dose, 160.0 mg/mL, 0.152 mg/mg, 0.85769 mg/mg, 59.55 mg/mL, 2.388 mg/mg, 2.382 mg/mg

Oral, , Powder, for solution, Powder, for solution - Oral, Powder, Powder - Oral, Powder, for solution - Topical, Topical, Cream, Cream - Topical, Liquid, Liquid - Ophthalmic, Ophthalmic, Gel - Nasal, Gel, Kit; Powder, for solution; Tablet, delayed release - Oral, Nasal, Spray, Gel - Topical, Solution, Solution - Oral, Liquid - Oral, Powder - Topical, Aerosol, metered - Nasal, Aerosol, metered, Powder, for suspension - Oral, Spray - Nasal, Kit - Oral, Kit, Powder, for solution - Nasogastric; Oral, Nasogastric; Oral, Kit - Oral; Topical, Oral; Topical, Nasogastric, Powder, for solution - Nasogastric, Oral; Rectal, Powder, for suspension, Kit; Powder, for solution; Tablet, delayed release, Spray, metered, Spray, metered - Nasal, Solution - Ophthalmic, Solution / drops, Solution / drops - Ophthalmic

Colonoscopy

, 1.7 mg/mg, 236.0 mg/mL, 17000.0 mg, 1700.0 mg/hour, 420.0 mg/mL, 17.0 mg/mg, 2.4 mg/mg, 4.2 mg/mg, 2.36 mg/mg, 227.1 mg/mL, 210.0 mg/mL, 1.0 mg/mg, 0.55 mg/mg, 100.0 %, 1.0 %, 15.0 %, 236000.0 mg, 59550.0 mg, 238180.0 mg, 14750.0 mg, 59000.0 mg, 240.0 mg/mL, 10.0 mg/mL, 150.0 mg/mL, 210000.0 mg, 0.15 mg/mg, 100.0 mg/mL, 40000.0 mg, 60.0 mg/mL, 100000.0 mg, 0.2 %, 140000.0 mg, 17000.0 mg/dose, 160.0 mg/mL, 0.152 mg/mg, 0.85769 mg/mg, 59.55 mg/mL, 2.388 mg/mg, 2.382 mg/mg

Oral, , Powder, for solution, Powder, for solution - Oral, Powder, Powder - Oral, Powder, for solution - Topical, Topical, Cream, Cream - Topical, Liquid, Liquid - Ophthalmic, Ophthalmic, Gel - Nasal, Gel, Kit; Powder, for solution; Tablet, delayed release - Oral, Nasal, Spray, Gel - Topical, Solution, Solution - Oral, Liquid - Oral, Powder - Topical, Aerosol, metered - Nasal, Aerosol, metered, Powder, for suspension - Oral, Spray - Nasal, Kit - Oral, Kit, Powder, for solution - Nasogastric; Oral, Nasogastric; Oral, Kit - Oral; Topical, Oral; Topical, Nasogastric, Powder, for solution - Nasogastric, Oral; Rectal, Powder, for suspension, Kit; Powder, for solution; Tablet, delayed release, Spray, metered, Spray, metered - Nasal, Solution - Ophthalmic, Solution / drops, Solution / drops - Ophthalmic

Constipation

, 1.7 mg/mg, 236.0 mg/mL, 17000.0 mg, 1700.0 mg/hour, 420.0 mg/mL, 17.0 mg/mg, 2.4 mg/mg, 4.2 mg/mg, 2.36 mg/mg, 227.1 mg/mL, 210.0 mg/mL, 1.0 mg/mg, 0.55 mg/mg, 100.0 %, 1.0 %, 15.0 %, 236000.0 mg, 59550.0 mg, 238180.0 mg, 14750.0 mg, 59000.0 mg, 240.0 mg/mL, 10.0 mg/mL, 150.0 mg/mL, 210000.0 mg, 0.15 mg/mg, 100.0 mg/mL, 40000.0 mg, 60.0 mg/mL, 100000.0 mg, 0.2 %, 140000.0 mg, 17000.0 mg/dose, 160.0 mg/mL, 0.152 mg/mg, 0.85769 mg/mg, 59.55 mg/mL, 2.388 mg/mg, 2.382 mg/mg

Oral, , Powder, for solution, Powder, for solution - Oral, Powder, Powder - Oral, Powder, for solution - Topical, Topical, Cream, Cream - Topical, Liquid, Liquid - Ophthalmic, Ophthalmic, Gel - Nasal, Gel, Kit; Powder, for solution; Tablet, delayed release - Oral, Nasal, Spray, Gel - Topical, Solution, Solution - Oral, Liquid - Oral, Powder - Topical, Aerosol, metered - Nasal, Aerosol, metered, Powder, for suspension - Oral, Spray - Nasal, Kit - Oral, Kit, Powder, for solution - Nasogastric; Oral, Nasogastric; Oral, Kit - Oral; Topical, Oral; Topical, Nasogastric, Powder, for solution - Nasogastric, Oral; Rectal, Powder, for suspension, Kit; Powder, for solution; Tablet, delayed release, Spray, metered, Spray, metered - Nasal, Solution - Ophthalmic, Solution / drops, Solution / drops - Ophthalmic

Exophthalmos

, 1.7 mg/mg, 236.0 mg/mL, 17000.0 mg, 1700.0 mg/hour, 420.0 mg/mL, 17.0 mg/mg, 2.4 mg/mg, 4.2 mg/mg, 2.36 mg/mg, 227.1 mg/mL, 210.0 mg/mL, 1.0 mg/mg, 0.55 mg/mg, 100.0 %, 1.0 %, 15.0 %, 236000.0 mg, 59550.0 mg, 238180.0 mg, 14750.0 mg, 59000.0 mg, 240.0 mg/mL, 10.0 mg/mL, 150.0 mg/mL, 210000.0 mg, 0.15 mg/mg, 100.0 mg/mL, 40000.0 mg, 60.0 mg/mL, 100000.0 mg, 0.2 %, 140000.0 mg, 17000.0 mg/dose, 160.0 mg/mL, 0.152 mg/mg, 0.85769 mg/mg, 59.55 mg/mL, 2.388 mg/mg, 2.382 mg/mg

Oral, , Powder, for solution, Powder, for solution - Oral, Powder, Powder - Oral, Powder, for solution - Topical, Topical, Cream, Cream - Topical, Liquid, Liquid - Ophthalmic, Ophthalmic, Gel - Nasal, Gel, Kit; Powder, for solution; Tablet, delayed release - Oral, Nasal, Spray, Gel - Topical, Solution, Solution - Oral, Liquid - Oral, Powder - Topical, Aerosol, metered - Nasal, Aerosol, metered, Powder, for suspension - Oral, Spray - Nasal, Kit - Oral, Kit, Powder, for solution - Nasogastric; Oral, Nasogastric; Oral, Kit - Oral; Topical, Oral; Topical, Nasogastric, Powder, for solution - Nasogastric, Oral; Rectal, Powder, for suspension, Kit; Powder, for solution; Tablet, delayed release, Spray, metered, Spray, metered - Nasal, Solution - Ophthalmic, Solution / drops, Solution / drops - Ophthalmic

Dry Eye Syndrome

, 1.7 mg/mg, 236.0 mg/mL, 17000.0 mg, 1700.0 mg/hour, 420.0 mg/mL, 17.0 mg/mg, 2.4 mg/mg, 4.2 mg/mg, 2.36 mg/mg, 227.1 mg/mL, 210.0 mg/mL, 1.0 mg/mg, 0.55 mg/mg, 100.0 %, 1.0 %, 15.0 %, 236000.0 mg, 59550.0 mg, 238180.0 mg, 14750.0 mg, 59000.0 mg, 240.0 mg/mL, 10.0 mg/mL, 150.0 mg/mL, 210000.0 mg, 0.15 mg/mg, 100.0 mg/mL, 40000.0 mg, 60.0 mg/mL, 100000.0 mg, 0.2 %, 140000.0 mg, 17000.0 mg/dose, 160.0 mg/mL, 0.152 mg/mg, 0.85769 mg/mg, 59.55 mg/mL, 2.388 mg/mg, 2.382 mg/mg

Oral, , Powder, for solution, Powder, for solution - Oral, Powder, Powder - Oral, Powder, for solution - Topical, Topical, Cream, Cream - Topical, Liquid, Liquid - Ophthalmic, Ophthalmic, Gel - Nasal, Gel, Kit; Powder, for solution; Tablet, delayed release - Oral, Nasal, Spray, Gel - Topical, Solution, Solution - Oral, Liquid - Oral, Powder - Topical, Aerosol, metered - Nasal, Aerosol, metered, Powder, for suspension - Oral, Spray - Nasal, Kit - Oral, Kit, Powder, for solution - Nasogastric; Oral, Nasogastric; Oral, Kit - Oral; Topical, Oral; Topical, Nasogastric, Powder, for solution - Nasogastric, Oral; Rectal, Powder, for suspension, Kit; Powder, for solution; Tablet, delayed release, Spray, metered, Spray, metered - Nasal, Solution - Ophthalmic, Solution / drops, Solution / drops - Ophthalmic

Bowel preparation therapy

, 1.7 mg/mg, 236.0 mg/mL, 17000.0 mg, 1700.0 mg/hour, 420.0 mg/mL, 17.0 mg/mg, 2.4 mg/mg, 4.2 mg/mg, 2.36 mg/mg, 227.1 mg/mL, 210.0 mg/mL, 1.0 mg/mg, 0.55 mg/mg, 100.0 %, 1.0 %, 15.0 %, 236000.0 mg, 59550.0 mg, 238180.0 mg, 14750.0 mg, 59000.0 mg, 240.0 mg/mL, 10.0 mg/mL, 150.0 mg/mL, 210000.0 mg, 0.15 mg/mg, 100.0 mg/mL, 40000.0 mg, 60.0 mg/mL, 100000.0 mg, 0.2 %, 140000.0 mg, 17000.0 mg/dose, 160.0 mg/mL, 0.152 mg/mg, 0.85769 mg/mg, 59.55 mg/mL, 2.388 mg/mg, 2.382 mg/mg

Oral, , Powder, for solution, Powder, for solution - Oral, Powder, Powder - Oral, Powder, for solution - Topical, Topical, Cream, Cream - Topical, Liquid, Liquid - Ophthalmic, Ophthalmic, Gel - Nasal, Gel, Kit; Powder, for solution; Tablet, delayed release - Oral, Nasal, Spray, Gel - Topical, Solution, Solution - Oral, Liquid - Oral, Powder - Topical, Aerosol, metered - Nasal, Aerosol, metered, Powder, for suspension - Oral, Spray - Nasal, Kit - Oral, Kit, Powder, for solution - Nasogastric; Oral, Nasogastric; Oral, Kit - Oral; Topical, Oral; Topical, Nasogastric, Powder, for solution - Nasogastric, Oral; Rectal, Powder, for suspension, Kit; Powder, for solution; Tablet, delayed release, Spray, metered, Spray, metered - Nasal, Solution - Ophthalmic, Solution / drops, Solution / drops - Ophthalmic

Chronic Constipation

, 1.7 mg/mg, 236.0 mg/mL, 17000.0 mg, 1700.0 mg/hour, 420.0 mg/mL, 17.0 mg/mg, 2.4 mg/mg, 4.2 mg/mg, 2.36 mg/mg, 227.1 mg/mL, 210.0 mg/mL, 1.0 mg/mg, 0.55 mg/mg, 100.0 %, 1.0 %, 15.0 %, 236000.0 mg, 59550.0 mg, 238180.0 mg, 14750.0 mg, 59000.0 mg, 240.0 mg/mL, 10.0 mg/mL, 150.0 mg/mL, 210000.0 mg, 0.15 mg/mg, 100.0 mg/mL, 40000.0 mg, 60.0 mg/mL, 100000.0 mg, 0.2 %, 140000.0 mg, 17000.0 mg/dose, 160.0 mg/mL, 0.152 mg/mg, 0.85769 mg/mg, 59.55 mg/mL, 2.388 mg/mg, 2.382 mg/mg

Oral, , Powder, for solution, Powder, for solution - Oral, Powder, Powder - Oral, Powder, for solution - Topical, Topical, Cream, Cream - Topical, Liquid, Liquid - Ophthalmic, Ophthalmic, Gel - Nasal, Gel, Kit; Powder, for solution; Tablet, delayed release - Oral, Nasal, Spray, Gel - Topical, Solution, Solution - Oral, Liquid - Oral, Powder - Topical, Aerosol, metered - Nasal, Aerosol, metered, Powder, for suspension - Oral, Spray - Nasal, Kit - Oral, Kit, Powder, for solution - Nasogastric; Oral, Nasogastric; Oral, Kit - Oral; Topical, Oral; Topical, Nasogastric, Powder, for solution - Nasogastric, Oral; Rectal, Powder, for suspension, Kit; Powder, for solution; Tablet, delayed release, Spray, metered, Spray, metered - Nasal, Solution - Ophthalmic, Solution / drops, Solution / drops - Ophthalmic

Obesity

, 1.7 mg/mg, 236.0 mg/mL, 17000.0 mg, 1700.0 mg/hour, 420.0 mg/mL, 17.0 mg/mg, 2.4 mg/mg, 4.2 mg/mg, 2.36 mg/mg, 227.1 mg/mL, 210.0 mg/mL, 1.0 mg/mg, 0.55 mg/mg, 100.0 %, 1.0 %, 15.0 %, 236000.0 mg, 59550.0 mg, 238180.0 mg, 14750.0 mg, 59000.0 mg, 240.0 mg/mL, 10.0 mg/mL, 150.0 mg/mL, 210000.0 mg, 0.15 mg/mg, 100.0 mg/mL, 40000.0 mg, 60.0 mg/mL, 100000.0 mg, 0.2 %, 140000.0 mg, 17000.0 mg/dose, 160.0 mg/mL, 0.152 mg/mg, 0.85769 mg/mg, 59.55 mg/mL, 2.388 mg/mg, 2.382 mg/mg

Oral, , Powder, for solution, Powder, for solution - Oral, Powder, Powder - Oral, Powder, for solution - Topical, Topical, Cream, Cream - Topical, Liquid, Liquid - Ophthalmic, Ophthalmic, Gel - Nasal, Gel, Kit; Powder, for solution; Tablet, delayed release - Oral, Nasal, Spray, Gel - Topical, Solution, Solution - Oral, Liquid - Oral, Powder - Topical, Aerosol, metered - Nasal, Aerosol, metered, Powder, for suspension - Oral, Spray - Nasal, Kit - Oral, Kit, Powder, for solution - Nasogastric; Oral, Nasogastric; Oral, Kit - Oral; Topical, Oral; Topical, Nasogastric, Powder, for solution - Nasogastric, Oral; Rectal, Powder, for suspension, Kit; Powder, for solution; Tablet, delayed release, Spray, metered, Spray, metered - Nasal, Solution - Ophthalmic, Solution / drops, Solution / drops - Ophthalmic

Eye

, 1.7 mg/mg, 236.0 mg/mL, 17000.0 mg, 1700.0 mg/hour, 420.0 mg/mL, 17.0 mg/mg, 2.4 mg/mg, 4.2 mg/mg, 2.36 mg/mg, 227.1 mg/mL, 210.0 mg/mL, 1.0 mg/mg, 0.55 mg/mg, 100.0 %, 1.0 %, 15.0 %, 236000.0 mg, 59550.0 mg, 238180.0 mg, 14750.0 mg, 59000.0 mg, 240.0 mg/mL, 10.0 mg/mL, 150.0 mg/mL, 210000.0 mg, 0.15 mg/mg, 100.0 mg/mL, 40000.0 mg, 60.0 mg/mL, 100000.0 mg, 0.2 %, 140000.0 mg, 17000.0 mg/dose, 160.0 mg/mL, 0.152 mg/mg, 0.85769 mg/mg, 59.55 mg/mL, 2.388 mg/mg, 2.382 mg/mg

Oral, , Powder, for solution, Powder, for solution - Oral, Powder, Powder - Oral, Powder, for solution - Topical, Topical, Cream, Cream - Topical, Liquid, Liquid - Ophthalmic, Ophthalmic, Gel - Nasal, Gel, Kit; Powder, for solution; Tablet, delayed release - Oral, Nasal, Spray, Gel - Topical, Solution, Solution - Oral, Liquid - Oral, Powder - Topical, Aerosol, metered - Nasal, Aerosol, metered, Powder, for suspension - Oral, Spray - Nasal, Kit - Oral, Kit, Powder, for solution - Nasogastric; Oral, Nasogastric; Oral, Kit - Oral; Topical, Oral; Topical, Nasogastric, Powder, for solution - Nasogastric, Oral; Rectal, Powder, for suspension, Kit; Powder, for solution; Tablet, delayed release, Spray, metered, Spray, metered - Nasal, Solution - Ophthalmic, Solution / drops, Solution / drops - Ophthalmic

Warnings

Nulytely has three contraindications and should not be taken together with the conditions indicated in the following table.

Nulytely Contraindications

Condition

Risk Level

Notes

Toxic colitis

Do Not Combine

Intestinal Perforation

Do Not Combine

Megacolon, Toxic

Do Not Combine

Gastric Retention

Do Not Combine

Gastrointestinal obstruction

Do Not Combine

Ileus

Do Not Combine

There are 20 known major drug interactions with Nulytely.

Common Nulytely Drug Interactions

Drug Name

Risk Level

Description

Bisacodyl

Major

The risk or severity of mucosal ulceration and ischemic colitis can be increased when Polyethylene glycol is combined with Bisacodyl.

Bisoxatin

Major

The risk or severity of mucosal ulceration and ischemic colitis can be increased when Polyethylene glycol is combined with Bisoxatin.

Dantron

Major

The risk or severity of mucosal ulceration and ischemic colitis can be increased when Polyethylene glycol is combined with Dantron.

Deacetylbisacodyl

Major

The risk or severity of mucosal ulceration and ischemic colitis can be increased when Polyethylene glycol is combined with Deacetylbisacodyl.

Oxyphenisatin

Major

The risk or severity of mucosal ulceration and ischemic colitis can be increased when Polyethylene glycol is combined with Oxyphenisatin.

image of a doctor in a lab doing drug, clinical research

Nulytely Novel Uses: Which Conditions Have a Clinical Trial Featuring Nulytely?

126 active clinical trials are being conducted to investigate the potential of Nulytely for the treatment of Dental Plaque, Methyl Alcohol Poisoning and Zollinger-Ellison Syndrome.

Condition

Clinical Trials

Trial Phases

Exophthalmos

2 Actively Recruiting

Phase 2, Phase 3

Constipation

17 Actively Recruiting

Phase 2, Not Applicable, Phase 4, Phase 3

Constipation

0 Actively Recruiting

Colon Cleansing for Colonoscopy

0 Actively Recruiting

Eye

0 Actively Recruiting

Chronic Constipation

1 Actively Recruiting

Not Applicable

Dry Eye Syndrome

8 Actively Recruiting

Phase 1, Phase 4, Not Applicable, Phase 2, Phase 3

Bowel preparation therapy

1 Actively Recruiting

Phase 1, Phase 2

Obesity

0 Actively Recruiting

Dry Eye Syndrome

6 Actively Recruiting

Phase 4, Not Applicable, Phase 2

Colonoscopy

3 Actively Recruiting

Not Applicable

Nulytely Reviews: What are patients saying about Nulytely?

5

Patient Review

10/9/2013

Nulytely for Emptying of the Bowel

I'm 72 and I had no problems with this drug! Some people might complain about the taste, but I think that's just because they're expecting it to be bad. Personally, I didn't find it too bad at all (I used the lemon flavoring).

4

Patient Review

3/3/2013

Nulytely for Emptying of the Bowel

I put this product in a blender and mixed it. It was like a milkshake and the taste was not nearly as bad and it was a heck of alot easier to drink. This is probably my 19th colonoscopy and finally I figured out how to get this product into me without the horrible gagging.

3.7

Patient Review

5/28/2014

Nulytely for Emptying of the Bowel

I am a 44 year old female and have used this prep four times before colonoscopies. The taste is unpalatable, to say the least. I don't understand why everyone, regardless of size, is supposed to drink an entire gallon. I've never been able to finish it, and it's incredibly unpleasant trying. I would prefer if my doctor was more forthcoming with information on when enough is enough.

3

Patient Review

10/10/2019

Nulytely for Emptying of the Bowel

Though this mixture is texturally similar to dog saliva, it works well. However, side effects include bloating, abdominal discomfort, headaches, runny nose, and horrible chills.

2

Patient Review

7/14/2009

Nulytely for Emptying of the Bowel

I really disliked this solution for a colonoscopy. I thought it was disgusting and refuse to have one because of it.

1.7

Patient Review

1/31/2010

Nulytely for Emptying of the Bowel

I was really turned off by this treatment. I hope there's something better out there.

1.7

Patient Review

4/24/2009

Nulytely for Emptying of the Bowel

I really hope there's a better way to do this colonoscopy prep because man, this stuff is awful. I've never been able to keep it down and even thinking about it makes me nauseous.

1

Patient Review

2/14/2010

Nulytely for Emptying of the Bowel

I tried to take this, but I got so nauseous that I threw up after the third glass. It was honestly the worst experience ever and I had to cancel my colonoscopy as a result. I really hope that medical professionals can come up with something better than this in the future because it's just not worth it.

1

Patient Review

8/24/2012

Nulytely for Emptying of the Bowel

I got very sick after only a few glasses. I was vomiting and dizzy, it was alarming.

Patient Q&A Section about nulytely

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Do you need a prescription for NuLYTELY?

"NuLYTELY is a prescription medicine that is used by adults to clean the colon before a colonoscopy."

Answered by AI

How long does it take NuLYTELY to work?

"Do not chew gum. NULYTELY's effects differ from patient to patient; sometimes the prep can start to work right away, while other times it may take 2-3 hours."

Answered by AI

Is NuLYTELY a laxative?

"NuLytely is a combination of a laxative and electrolytes that is used for bowel cleansing prior to colonoscopy and barium enema X-ray examination in adults."

Answered by AI

What is NuLYTELY used for?

"PEG is a laxative that is used to clean out the intestines before certain procedures, such as a colonoscopy or barium enema X-ray. It works by drawing large amounts of water into the colon, which results in watery bowel movements."

Answered by AI

Clinical Trials for Nulytely

Image of Eye Research Foundation /ID# 267931 in Newport Beach, United States.

ABBV-444 for Dry Eye Syndrome

18+
All Sexes
Newport Beach, CA

Dry Eye Disease (DED) refers to a long-term condition that happens when there is not enough lubrication in your eyes. This can happen when your eye cannot make enough tears or if you make poor-quality tears. The purpose of this study is to compare the efficacy and safety of a new artificial tear formulation (ABBV-444) with Refresh Optive UD for 90 days in participants with Dry Eye Disease (DED. ABBV-444 is being developed for the treatment of Dry Eye Disease (DED). Participants will be placed into 1 of 2 treatment arms. Each group receives different treatment. Adult participants diagnosed with dry eye disease will be enrolled. Around 250 participants will be enrolled in the study at approximately 20 sites across the US In this study, participants first complete a 7-day run-in period using REFRESH PLUS® eye drops. Those eligible are then randomized to receive ABBV-444 eye drops or REFRESH OPTIVE® Unit Dose eye drops. Participants in both arms will receive treatment for a 90-day treatment period. There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend multiple required study visits during the study at the study site. The effect of the treatment will be checked by medical assessments and questionnaires.

Phase 3
Recruiting

Eye Research Foundation /ID# 267931 (+9 Sites)

ABBVIE INC.

AbbVie

Image of Center for Sight in Las Vegas, United States.

Acoltremon for Dry Eye Syndrome

18+
All Sexes
Las Vegas, NV

Dry eye disease (DED) is a common, chronic and multifactorial disease of the ocular surface presenting with signs and symptoms of ocular discomfort, visual disturbance and fluctuation, tear film instability, ocular surface inflammation and damage. It significantly affects patients' quality of life and is one of the most frequent reasons for visits to eye care providers. Many patients remain symptomatic in real-world settings despite current pharmacologic therapeutic options available. As symptoms often lag behind ocular signs, a 3 month study with multiple time points has been designed to assess short term and mid-term symptomatic changes. This study will use Dry Eye Surveys to evaluate Acoltremon in Real World Settings to help understand its real world effectiveness and potential to improve symptoms in dry eye patients.

Phase 4
Waitlist Available

Center for Sight

Image of Kannar Eye Care in Pittsburg, United States.

Acoltremon for Dry Eye Syndrome

18 - 75
All Sexes
Pittsburg, KS

This 1-month, 3-visit study will be conducted at the Southern College of Optometry (Memphis, TN), Kannarr Eye Care, LLC (Pittsburg, KS) and Complete Eye Care of Medina (Minneapolis, MN). Adults ≥18 years of age who have been diagnosed with DED for at least 6 months and who are currently symptomatic (Eye Dryness VAS Score ≥40) will be recruited. Subjects will have an abnormal Schirmer test of \<10 mm/5 min. Subjects will also be required to score ≤70 on the IDEEL Quality of Life (QoL) Work domain to ensure that their DED symptoms are significantly impacting their ability to do work.9 Subjects will be required to have corrected distance visual acuity of 20/32 (0.2 logMAR) or better.

Phase 4
Recruiting

Kannar Eye Care (+2 Sites)

Have you considered Nulytely clinical trials?

We made a collection of clinical trials featuring Nulytely, we think they might fit your search criteria.
Go to Trials

Have you considered Nulytely clinical trials?

We made a collection of clinical trials featuring Nulytely, we think they might fit your search criteria.
Go to Trials

Have you considered Nulytely clinical trials?

We made a collection of clinical trials featuring Nulytely, we think they might fit your search criteria.
Go to Trials